ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...

ProMIS Neurosciences Inc. (Nasdaq: PMN) (“ProMIS” or the “Company”), a clinical-stage biotechnology company focused on the ...

Extends cash runway into 2028 Proceeds expected to enable completion of ProMIS' landmark Phase 1b AD study and support execution of key clinical milestones Blinded 6-month top-line data expected ...

As NASA readies itself for the Artemis II mission to the moon, experts have revealed everything that could go wrong on the daring space voyage.

Space looks peaceful from the outside. Astronauts float effortlessly, their movements fluid and graceful against the backdrop ...

DNA is often described as the instruction manual for building the fundamental components of life. Proteins are helpers that ...

Our thoughts are with those who have lost a loved one ...

New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting more than ...

Deficiencies in vitamins and minerals like magnesium, iron, vitamin B12, vitamin D, and vitamin C can affect your energy and leave you feeling tired often.